XOMA Corp
LSE:0M26
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X
|
XOMA Corp
LSE:0M26
|
US |
|
Outlook Therapeutics Inc
F:41O
|
US |
|
Dermapharm Holding SE
XETRA:DMP
|
DE |
|
XOMA Corp
NASDAQ:XOMA
|
US |
|
X
|
XOMA Corp
F:X0M1
|
US |
|
D
|
Dermapharm Holding SE
XMUN:DMP
|
DE |
Wall St Price Targets
0M26 Price Targets Summary
XOMA Corp
According to Wall Street analysts, the average 1-year price target for 0M26 is 45.379 USD with a low forecast of 39.381 USD and a high forecast of 52.487 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0M26's stock price target?
Price Target
45.379
USD
According to Wall Street analysts, the average 1-year price target for 0M26 is 45.379 USD with a low forecast of 39.381 USD and a high forecast of 52.487 USD.
What is the Revenue forecast for XOMA Corp?
Projected CAGR
26%
Over the last 14 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 8 years is 26%.
What is the Operating Income forecast for XOMA Corp?
Projected CAGR
24%
The compound annual growth rate for Operating Income over the next 5 years is 24%.
What is the Net Income forecast for XOMA Corp?
Projected CAGR
-32%
The compound annual growth rate for Net Income over the next 3 years is -32%.
